Global Neurorehabilitation Devices Market Growth (Status and Outlook) 2023-2029

Global Neurorehabilitation Devices Market Growth (Status and Outlook) 2023-2029

Neurorehabilitation devices helps to improve function, reduce symptoms and improve the wellbeing of people with diseases such as trauma or disorders of the nervous system. Infections, tumours, disorders, degenerative diseases, injuries and structural defects in the circulatory system can impair the nervous system.
LPI (LP Information)' newest research report, the “Neurorehabilitation Devices Industry Forecast” looks at past sales and reviews total world Neurorehabilitation Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Neurorehabilitation Devices sales for 2023 through 2029. With Neurorehabilitation Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurorehabilitation Devices industry.
This Insight Report provides a comprehensive analysis of the global Neurorehabilitation Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurorehabilitation Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurorehabilitation Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurorehabilitation Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurorehabilitation Devices.
The global Neurorehabilitation Devices market size is projected to grow from US$ 1315.2 million in 2022 to US$ 3087.8 million in 2029; it is expected to grow at a CAGR of 13.0% from 2023 to 2029.
North America is the largest consumption place for Neurorehabilitation devices, with a consumption market share over 40%, followed by Europe. Medtronic, Abbott, Boston Scientific, Bioness and Hocoma AG are the major manufacturers in this industry, with Medtronic having the largest market share, exceeding 30%. The classification of Neurorehabilitation devices includes Implantable Neurorehabilitation System, Neurorobotic System, Brain Computer Interface, Non-invasive Stimulators, etc. They have been widely used in hospitals and clinics
This report presents a comprehensive overview, market shares, and growth opportunities of Neurorehabilitation Devices market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Implantable Neurorehabilitation System
Neurorobotic System
Brain Computer Interface
Non-invasive Stimulators
Other
Segmentation by application
Hospitals
Clinics
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Abbott Laboratories
Boston Scientific
Bioness
Hocoma AG
Neuronetics
Yiruide
Magstim
VISHEE
Ekso Bionics
Alter G
MagVenture
Tyromotion
Soterix Medical
Neuroelectrics
Bionik Laboratories
Helius Medical

Please note: The report will take approximately 2 business days to prepare and deliver.